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Introduction 
The development of de novo malignancies is a well-
recognized complication of the immunosuppressed 
state that follows organ transplantation (1-6). In 
the cyclosporine era, lymphomas, skin cancer and 
Kaposi's sarcoma account for more than half of the 
reported cases (6). Other tumors of mesenchymal 
origin are uncommon. 
We describe a case of a primary smooth muscle 
tumor arising in a liver allograft. The tumor was 
of donor origin. To our knowledge this compli-
cation has not been seen before. 
Case Rellort 
An 18-month old white female underwent orthoto-
pic liver transplantation for biliary atresia in April 
of 1986. Immunosuppression was with cyclospor-
ine and prednisone. She had previously undergone 
a Kasai procedure at the age of 2 months. The 
donor was a healthy 22-month-old black male who 
died of a closed head injury. A complete autopsy 
was subsequently performed, which revealed only 
bilateral subdural hematomas. The kidneys were 
also harvested, and transplanted en bloc into a 53-
year-old female. 
The patient's post-operative course was initially 
complicated by steroid-resistant rejection, which 
was successfully treated with OKT3. She later de-
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veloped cortical blindness of unknown etiology, 
foHowing an episode of grand mal seizure, but this 
resolved gradually over the next several months. 
Abdominal ullrasounds were performed over the 
next several weeks (4, 12, 21, and 29 days post-
transplant). None of these showed a hepatic pai'ft'"1 fJ("tMh, '" 
cbymal lesion. An abdominal CT scan performed 
on post-op d 25 also showed a normal liver. She 
was discharged on cyclosporine and prednisone (60 
mgfkg and 0.75 mgfkg respectively), with normal 
liver function. In May of 1989 a routine follow-up 
abdominal ultrasound revealed a single, hypoecho-
ic lesion in the left lobe of the liver measuring 3 x 2 
em. A CT scan of the abdomen confirmed this 
finding, but was otherwise unremarkable. At the 
time she was completely asymptomatic, and her 
physical examination was also unremarkable. 
Total bilirubin was 0.2 mgldl, alkaline phospha-
tase was 267 ull, GOTP 53 ull, SOOT 31 ufl, and 
SOPT 22 ufl. Prothrombin time was 12.2 seconds. 
Alpha fetoprotein was < 2 ng/ml and CEA 1.2 ngl 
ml. 
An ultrasound-guided biopsy showed fibroadi-
pose tissue, plus a moderately cellular minute por-
tion of tissue composed of wavy, thin, elongated 
cells that stained OJ positively with muscle-
specific actin. 
The patient underwent a left lateral segmentecto-
my. Thorough exploration of the abdominal cavity 
failed to reveal any additional pathology. 
The resection specimen measured 10 x 7 x 3.5 cm 
and contained a 3 cm tumor with clean lines of resec-
tion. The tumor was oval and encapsulated except 
for two small satellite nodules adjacent to it, each 
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measuring 0.7 cm in diameter. It was composed of 
interlacing bundles of spindle cells (Fig. 1) tightly 
packed in some areas with some cellular pleomor-
phism focally. The nuclei were long, blunt-ended 
and sometimes wavy. It had focal areas of necrosis, 
possibly corresponding to a previous biopsy site. 
Mitoses were less than 1/10 HPF. Tumor cells 
stained with desmin focally and with muscle-specific 
actin, but not withS 100 protein, suggesting a muscle 
origin. This was proven by electron microscopy 
(Fig. 2). The tumor cells had a well-defined base-
ment membrane, masses of cytoplasmic filaments 
with dense bodies, scattered electron-dense conden-
sations along the plasma membrane and numerous 
pinocytotic vesicles as well as abundant glycogen. 
The liver and tumor tissues, as well as positive and 
negative controls, were studied with a probe comple-
mentary to a repeated sequence on the Y -chromo-
some labeled with biotinylated d-UTP by the ran-
dom priming method. The tumor showed a male 
pattern indicative of its donor origin. 
The patient made an uneventful recovery. Post-
operatively a CT scan of the chest was obtained 
that showed only left lower lobe atelectasis, which 
was attributed to her recent surgery. A bone scan 
was negative. She was discharged with normal liver 
function. She is currently doing well 8 months fol-
lowing the resection. 
DlsCDssi •• 
Any state of immunodeficiency, whether congenital 
acquired or iatrogenic, is complicated by an in-
creased incidence of certain neoplasms (1-6). Since 
the early days of renal transplantation malignant 
disease has been recognized as a significant hazard, 
rig. 1. Interlacing bundles of elongated cells showing some 
nuclear variation, perinuclear clearing and distinct cell borders. 
H&E stain. 
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Fig. 2. Electron micrograph illustrating tumor cells with fea-
tures of smooth muscle: basement membrane, pinocytoxic ves-
icles, masses of cytoplasmic filaments with scattered electron 
densities and glycogen. 
with an incidence ranging from 1 % to 16%, and 
an average of 6.1 % (6). 
Although the inadvertent transplantation of ma-
lignant tumors continues to occur sporadically de-
spite careful screening of donors (7), most of these 
tumors arise de novo. In the cyclosporine era, im-
munosuppression therapy is complicated by a rela-
tively high incidence of non-Hodgkin's lymphoma, 
skin cancer, and Kaposi's sarcoma (6). 
In the particular case of liver transplantation, 
the Cambridge group reported a series of 122 pa-
tients who survived for 3 months or more, among 
whom 7 de novo tumors were found (8). These 
included a patient described as having a reticulum 
cell sarcoma of host origin that developed in the 
grafted liver (8, 9). The remaining 6 patients had 
extrahepatic neoplasms, including a case of small 
bowel leiomyoma. To the best of our knowledge 
our case represents the first instance of a primary 
liver tumor, that is, of donor origin, to be reported 
in a liver transplant patient. 
Primary smooth muscle tumors of the liver are 
rare entities and we were only "able to find 21 re-
ported cases in the literature (10-13). Four were lei-
omyomas and the rest were primary hepatic lei-
omyosarcomas. Clinical information was provided 
in 20 of these cases. There were 13 females and 7 
males, with an age range of]2 to 86 yr. Most pre-
sented with an abdominal mass or hepatomegaly 
(10,11). 
Smooth muscle tumors seem to represent a bio-
logical continuum in which one is forced to draw 
certain arbitrary lines in designating some as "be-
nign" and others as "malignant". A number of 
features such as size, cellularity, atypia, and necros-
is correlate to some extent with malignancy, with 
mitotic activity being the most accurate and repro-
ducible. Even this last criterion, however, is subor-
dinate to the organ of origin (14). Because of their 
rarity it is very difficult to set forth criteria that 
will distinguish benign from malignant variants in 
cases of primary hepatic smooth muscle tumors. 
Leiomyosarcomas are described as having cells 
with hyperchromatic nuclei, with considerable 
variation in size, and frequent mitoses (one or more 
per high-power field) (15). In the 2 reported cases 
of leiomyoma that have addressed this issue, mito-
ses were rare (less than 1/10 high-power fields) (16). 
By analogy with other gastrointestinal smooth 
muscle tumors it is to be expected that, although 
a combined assessment of size, cellularity, and 
cellular atypia conveys some impression of the ag-
gressive potential of these neoplasms, absolute cri-
teria for the diagnosis of malignancy cannot be 
established. 
The case we present, with its low mitotic rate, 
focally highly cellulax., and areas of necrosis, falls 
into an indeterminate category. Treatment consists 
of resection with a margin of normal liver. The 
unpredictability of these tumors mandates a careful 
and life-long follow-up. 
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